IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide

By sjmartinez • January 3, 2024

Silva BJA, Krogstad PA, Teles RMB, Andrade PR, Rajfer J, Ferrini MG, Yang OO, Bloom BR, Modlin RL. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide. Front Immunol. 2023 Dec 15;14:1284148. doi: 10.3389/fimmu.2023.1284148. PMID: 38162653; PMCID: PMC10755032.

Tags: CD8 lymphocytes, covid-19, Dermatology, Infectious Diseases, interferon, Nitric oxide, Publications, SARS-CoV-2, T cell response, viral immunity

A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers

Algazi AP, Moon J, Lao CD, Chmielowski B, Kendra KL, Lewis KD, Gonzalez R, Kim K, Godwin JE, Curti BD, Latkovic-Taber M, Lomeli SH, Gufford[...]

Protocol for isolating amnion cells from human and non-human primate placenta for flow cytometry and transcriptomics

Cappelletti M, Short D, Morselli M, Pellegrini M, Johnson MR, Afshar Y, Kallapur SG, Presicce P. Protocol for isolating amnion cells from human and non-human[...]

Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod

Ghafari-Saravi A, Haussmann A, Wu J, Cheng K. Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod. JAAD Case Rep. 2024 Mar 15;47:68-71. doi:[...]